XML 85 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from Operating Activities      
Loss for the year $ (15,439) $ (14,657) $ (15,942)
Adjustments to reconcile loss to net cash used in operating activities: 3,578 3,184 11,151
Net cash used in operating activities (11,861) (11,473) (4,791)
Cash Flows from Investing Activities      
Changes in short term deposits 7,273 (337) (11,779)
Investment in affiliated company   (5,065)  
Proceeds from sales of other investments 21    
Purchase of fixed assets (103) (733) (271)
Net cash provided by (used in) investing activities 7,191 (6,135) (12,050)
Cash flows from Financing Activities      
Issuance of ordinary shares and warrants, net of issuance expenses 6,521 11,208 10,745
Proceeds from exercise of warrants   125 12,009
Proceeds from exercise of options   34 641
Net cash provided by financing activities 6,521 11,367 23,395
Effect of exchange rate changes on cash and cash equivalents (182) (237) (282)
Increase (decrease) in cash and cash equivalents 1,669 (6,478) 6,272
Cash and cash equivalents at the beginning of the period 3,158 9,636 3,364
Cash and cash equivalents at the end of the period 4,827 3,158 9,636
Share-based payment 1,638 2,040 2,455
Depreciation 259 235 49
Revaluation of derivative warrant liabilities 1 (2,071) 12,180
Equity in net loss (gain) of an affiliated company 839 2,905 (156)
Revaluation of other investments 324 (316) (3,967)
Revaluation of securities classified as trading   (1) (4)
Exchange rate changes on cash and cash equivalents 182 237 282
Changes in assets and liabilities:      
Decrease (Increase) in other current assets (142) 11 (378)
Increase in trade payables 154 14 226
Change in operating lease liability 110    
Decrease in other payables 213 130 464
Adjustments to reconcile loss to net cash used in operating activities $ 3,578 3,184 $ 11,151
Exercise of warrant investment (see note 4C2)   $ 4,004